Option chain shows key data for Sienna Biopharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sienna Biopharmaceuticals.

Sienna Biopharmaceuticals (OTC:SNNAQ) Stock, Option Chain

Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.

News

Intraday Update

Markets

Movers

Trading Ideas

ABEV

ABIO

ABMD

ABVC

ACCYY

ACHV

ACIW

ACOR

ACRFF

ACRX

ACSAY

ACST

ADHC

ADMA

ADMP

AEGOF

AFLYY

AFRAF

AGCO

AGEEF

AHKSY

AHOTF

AIBGY

AIPUY

AKRX

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALLY

ALMFF

ALOT

ALSN

ALTM

ALXN

AMADY

AMCX

AMKBF

AMKBY

AMNP

AMPH

AMRH

AMRQQ

AMTX

ANAT

ANCN

ANGO

ANIP

ANZLY

APEX

APHA

APLE

APTS

AQARF

ARCB

ARCH

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARTL

ASNA

ASTVF

ATRA

ATRI

ATROB

ATSG

ATUSF

AUTL

Stocks That Hit 52-Week Lows On Thursday

Movers & Shakers

General

AMIH

APRN

BCCMY

BNXR

BTKGF

CBDEF

CEIX

CGEI

CIMEF

CMGHY

COFE

CONN

CORX

CTXDF

DCTHD

DLPH

DLRYF

DRTT

ENTA

FQVTF

FRBK

GBPT

GPOR

GTLL

HGSH

HNRG

HPYCF

HWKE

IDLM

IMTO

JBZY

JRNGF

KEQU

KGET

KONAQ

LFCOF

LKCO

MCUJF

MICFF

MMJJF

NABIF

NAKD

NMGC

NVGI

OLLI

PPJE

PRTT

RNLSY

SEEK

SMTTF

SYNNF

TAST

TVOG

UIHC

VBIX

VISIUM TECHNOLOGIES INC by Visium Technologies, Inc.

VISM

WDHR

WKRCF

YGYI

CFEIY

SNNAQ

Stocks That Hit 52-Week Lows On Tuesday

AONCF

APTY

ARGQ

ARST

BDCO

BDRAF

BDRBF

CHYHY

CNTMF

COWI

FLDPF

FUTL

GARB

GOTRF

GWRRF

HESG

HLFDF

IMBI

INND

LIXT

MINE

ORAN

ORVRF

SGRWF

SVSN

TBEV

TGRO

UAMA

ALIZY

SIENNA BIOPHARMACEUTICALS by Sienna Biopharmaceuticals, Inc.

Sienna Biopharmaceuticals Inc

These eleven large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) shares dipped 20.52% after the company released headline results from the REDEFINE 1 Phase 3 <a href="https://www.benzinga.com//node/42613036" target="_blank" rel="noreferrer noopener">trial in the global REDEFINE program</a>.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) stock declined 14.33% after the company announced results from its <a href="https://www.benzinga.com//node/42599745" target="_blank" rel="noreferrer noopener">Phase 2 study of Suzetrigine</a>.</li>
<li>XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) shares were down 13.47%.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares fell 13.33% last week as the company is <a href="https://www.benzinga.com//node/42520765" target="_blank" rel="noreferrer noopener">set to be removed</a> from the Nasdaq 100 Index.</li>
<li>Nu Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) stock plummeted 13.07%. A new government fiscal spending package and last week&#8217;s central bank rate hike could erode global investor confidence and raise concerns over the nation&#8217;s deficit.</li>
<li>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) stock was down 13.01%, likely due to continued weakness stemming from its <a href="https://www.benzinga.com//node/42538739" target="_blank" rel="noreferrer noopener">ongoing legal dispute</a> with Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>).</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) shares decreased 12.08% after the company reported mixed earnings results and issued weak guidance for the current quarter. <a href="https://www.benzinga.com//node/42594359" target="_blank" rel="noreferrer noopener">Multiple analysts also lowered price forecasts</a>.</li>
<li>Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) stock lost 11.63% last week, a result of the Fed rate decision that caused a selloff in software stocks.</li>
<li>Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) stock declined 11.50% after the company reported <a href="https://www.benzinga.com//node/42588404" target="_blank" rel="noreferrer noopener">second-quarter financial results</a>. Several analysts lowered <a href="https://www.benzinga.com/quote/ctas/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) <a href="https://www.benzinga.com//node/42603589" target="_blank" rel="noreferrer noopener">declined 11.43%</a>.</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) stock dived 11.20% after Citigroup cut its price forecast <a href="https://www.benzinga.com/quote/mndy/analyst-ratings" target="_blank" rel="noreferrer noopener">on the stock from $338 to $302</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/12/42638256/teva-pharmaceutical-li-auto-and-darden-restaurants-are-among-top-large-cap-gainers-last-week-december-16-20-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Large Cap

CTAS

CVNA

MNDY

MSTR

PAYC

QCOM

SMCI

VRTX

Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?

It's that time of year again. Holiday tunes on the radio, twinkling lights everywhere and a hefty dose of pressure to deliver the "perfect" Christmas. But what happens when you're juggling debt, young kids and the harsh reality that you're barely making ends meet? That's where Joshua found himself when he called into The Ramsey Show.&nbsp;
In a video posted in December titled, "Buy My Kids Christmas Gifts or Pay Off Debt?", <a href="https://www.benzinga.com/personal-finance/24/12/42488891/dave-ramsey-scolds-broke-61-year-old-with-no-money-who-splurged-on-a-26000-tractor-quit-blaming-dumb-stuff-on-being-a-country-girl">Dave Ramsey</a> and his co-host daughter, Rachel Cruze, didn't hold back.
At just 24 years old, Joshua – a medically retired military veteran – shared a tough predicament. "We ran into some financial hardship … and with Christmas coming up, I have three young children. I'm wondering, should I sacrifice their happiness Christmas morning to continue to pay off this debt?"
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
On paper, Joshua's situation looks tight. With $1,800 in credit card debt and $4,000 in collections, plus a family of five to support, his question wasn't unreasonable. But Dave Ramsey and co-host Rachel Cruze didn't sugarcoat their advice.
"Absolutely, you need a job," Dave said point-blank. Joshua, currently in school full-time, explained he was studying business administration with a focus on project management. His plan was to complete his degree without working for the next four years. Meanwhile, his wife stays home with their three young kids, including a newborn.
That plan didn't fly with Dave. "I worked 40 to 60 hours a week while I was going to school," he reminded Joshua. The bottom line? While education is important, it can't come at the expense of providing for your family.
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
Joshua mentioned he's earning around $6,000 a month from his military pension, but as Dave pointed out, "You can save up the money for Christmas by working during this month." The advice? Start driving for Uber, delivering with Grubhub or picking up any available gig.
Rachel chimed in with a mom's perspective, reassuring Joshua – and every parent out there – that <a href="https://www.benzinga.com/personal-finance/24/12/42317960/warren-buffett-used-to-gift-loved-ones-10000-cash-for-christmas-but-switched-to-stocks-with-a-note-cash-them-in-or-hold-onto-them">Christmas doesn't have to be expensive</a> to be meaningful. "Kids are so low maintenance," she said. "Go so cheap … they just want the experience of opening gifts."
She also shared a personal anecdote: "We spent all this stinking money on Christmas and Uncle Mac went to the dollar store, spent 20 bucks and was the biggest hit. All kids care about is opening something!"
Dave added with his usual wit, "The newborn doesn't even know it's Christmas. Feed them, change their diaper and they're a happy puppy."
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Beyond Christmas, the real focus was on Joshua's long-term plan. "You only need $5,800 to be debt-free," Dave emphasized. "You could have that by March." He urged Joshua to keep working after the holidays, balancing his job with his online classes to dig out of debt and set his family up for financial success.
And for parents everywhere, Rachel left a crucial reminder: "Your kids want you. The stuff doesn't matter. Create experiences, not expenses."
Joshua's story is a wake-up call for anyone feeling the pressure of the holiday. Christmas doesn't have to come with a <a href="https://www.benzinga.com/news/24/12/42392068/elon-musks-ex-wife-says-he-forgot-to-buy-her-a-christmas-gift-but-when-he-realized-he-walked-barefoot-in-a-snowstorm-to-find-flowers">price tag you can't afford.</a> Whether delivering pizzas or picking up extra shifts, there's always a way to make it work without sacrificing your financial health. And remember, your kids will cherish the memories you create far more than the stuff you buy.
So this year, keep it simple. Ride bikes, bake cookies or hit the dollar store for a garbage bag full of joy. Your wallet – and your kids – will thank you.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>

Personal Finance

'Buy My Kids Christmas Gifts Or Pay Off Debt?' – Young Dad Of 3 Asks Dave Ramsey If He Should 'Sacrifice Their Happiness' Christmas Morning?

Mark Cuban, the serial entrepreneur and investor best known for his role on &#8220;Shark Tank,&#8221; had a surprisingly simple goal when he became a millionaire: avoid <a href="https://www.benzinga.com/news/24/12/42380812/mark-cuban-shares-the-one-thing-he-splurged-on-after-striking-it-rich-im-not-a-big-spender">spending all his money at once</a>.
What Happened: After selling his software company, MicroSolutions, for $6 million in 1990 and pocketing about $2 million after taxes, Cuban adopted a conservative investment approach to preserve his newfound wealth.
"I want you to invest for me like a 60-year-old. I don't want you to invest like I'm young, because I want to live off this for a long time," Cuban recalled telling his broker at the time and <a href="https://www.youtube.com/watch?v=oEK2063FPLw">shared</a> this in a recent interview.
This strategy, along with his frugal lifestyle, allowed him to safeguard his wealth while still enjoying occasional splurges.
Cuban's modest upbringing as the son of an automobile upholsterer near Pittsburgh shaped his cautious approach to money. 
Even after becoming a millionaire, he lived below his means, buying "the worst house in the best neighborhood" and steering clear of flashy cars. 
"By the time I sold MicroSolutions, I had just bought the worst house in the best neighborhood, but I wasn't big into that. I wasn't big into cars. I wanted to live like a student and just have fun," Cuban said. 
However, one notable indulgence was a $125,000 lifetime pass with American Airlines, which he used to "party like a rock star" across cities with his friends.
Also Read: <a href="https://www.benzinga.com/news/24/10/41196856/heres-how-mark-cubans-drunken-splurge-of-125-000-turned-into-a-profitable-investment">Mark Cuban Drunkenly Bought A $125,000 Lifetime Flight Pass And Turned It Into A Profitable Investment</a>
His financial perspective shifted dramatically in 1999 when he sold his second company, Broadcast.com, for $5.7 billion. The windfall gave Cuban the freedom to take more significant risks, a mindset he has carried into his investing career. 
Cuban has said that smart risks are essential to building wealth, reflecting his evolution from a cautious millionaire to a bold billionaire.
Today, Cuban focuses on his family and running Cost Plus Drugs, his pharmaceutical startup aimed at lowering prescription drug costs. While his days of lavish partying are behind him, he remains dedicated to making a positive impact. "I think less about making money and more about direction and&#8230;benefit[ing] as many Americans as I can," Cuban said during the interview.
Read Next
<a href="https://www.benzinga.com/news/24/11/41703723/mark-cubans-million-dollar-advice-to-teens-if-i-were-16-again-id-start-this-lucrative-side-hustle">Mark Cuban&#8217;s Million-Dollar Advice To Teens: &#8216;If I Were 16 Again, I&#8217;d Start This Lucrative Side Hustle&#8217;</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Success Stories

Mark Cuban's Wealth Journey: 'I Want to Live Off This for a Long Time'

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Teva Pharmaceutical Industries Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) stock escalated 33.88% after the company and Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) announced that primary endpoints were met in the Phase 2b trial of Duvakitug for <a href="https://www.benzinga.com//node/42531132" target="_blank" rel="noreferrer noopener">ulcerative colitis and Crohn&#8217;s disease</a>.</li>
<li>Klaviyo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) shares surged 12.85%.</li>
<li>Olive Garden parent Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) stock rose 12.54% after the company reported better-than-expected second-quarter EPS and <a href="https://www.benzinga.com//node/42585797" target="_blank" rel="noreferrer noopener">issued an FY25 revenue outlook</a>. Several analysts raised the <a href="https://www.benzinga.com/quote/dri/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) shares upped 10.91%. Stephens &amp; Co. initiated coverage with an Equal-Weight rating and <a href="https://www.benzinga.com/quote/docs/analyst-ratings" target="_blank" rel="noreferrer noopener">a price forecast of $55</a>.</li>
<li>Birkenstock Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) shares increased 9.70% after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance. Several analysts raised <a href="https://www.benzinga.com//node/42599431" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) stock upped 7.30% after the company reported better-than-expected <a href="https://www.benzinga.com//node/42553094" target="_blank" rel="noreferrer noopener">first-quarter EPS and revenues</a>. Several analysts raised <a href="https://www.benzinga.com/quote/jbl/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Neurocrine Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) stock rose 6.88%. The FDA approved Crenessity (crinecerfont) capsules and oral solution as an adjunctive treatment to glucocorticoid replacement to control androgens in adult and pediatric patients four years of age and older with <a href="https://www.benzinga.com//node/42508449" target="_blank" rel="noreferrer noopener">classic congenital adrenal hyperplasia (CAH).</a></li>
<li>GameStop Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) stock was up 6.54% last week, continuing strength from Q3 earnings.</li>
<li>Dr. Reddy&#8217;s Laboratories Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDY#NYSE">RDY</a>) stock increased 6.29%.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) shares upped 6.13% last week.</li>
</ol>
Photo by Sundry Photography via Shutterstock

BIRK

CHWY

DOCS

KVYO

NBIX

TEVA

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

Comments

Sienna Biopharmaceuticals

Sienna Biopharmaceuticals (SNNAQ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga